Anthem (ANTM): DOJ Settlement Still Unlikely - FBR
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
FBR Capital analyst, Chris Meekins, believes the news report implying an increased likelihood of a settlement between the Department of Justice (DOJ) and Anthem (ANTM) may have created confusion among investors about what actually occurred at the August 12 hearing. After reviewing the transcript, he believes that nothing in the hearing stated that a settlement was under active consideration.
The analyst notes that the DOJ could not reach a settlement with Aetna and Humana despite "the complaint that it filed only involving two markets and divestitures being easier to find. The idea that the DOJ will find a settlement in a case with a complaint that involves four markets when the DOJ has made clear the general structure that it would require—and ANTM did not even attempt a proposal that would meet that structure during the investigation stage". He believes this makes a settlement extremely unlikely before the trial date of November 21, 2016.
Market Perform Anthem (NYSE: ANTM) price target of $155.00
Shares of Anthem closed at $130.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Federal Judge to Block Anthem (ANTM), Cigna Corp. (CI) Merger - NYP
- UPDATE: SunTrust Robinson Humphrey Downgrades Simon Property Group (SPG) to Hold
- Anthem (ANTM) Extends Cigna (CI) Merger Termination Date Until April 30, 2017
Create E-mail Alert Related CategoriesAnalyst Comments, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!